Chugai Pharmaceutical Co., Ltd. (CHGCY)
22.51
+0.33
(+1.49%)
USD |
OTCM |
Nov 13, 16:00
Chugai Pharmaceutical EPS Diluted (Quarterly) : 0.2739 for Sept. 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 0.2739 |
| June 30, 2026 | 0.2218 |
| March 31, 2026 | 0.2235 |
| December 31, 2025 | 0.2532 |
| September 30, 2025 | 0.2292 |
| June 30, 2025 | 0.2042 |
| March 31, 2025 | 0.1938 |
| December 31, 2024 | 0.1826 |
| September 30, 2024 | 0.2229 |
| June 30, 2024 | 0.2181 |
| March 31, 2024 | 0.1523 |
| December 31, 2023 | 0.1874 |
| September 30, 2023 | 0.1631 |
| June 30, 2023 | 0.1838 |
| March 31, 2023 | 0.1687 |
| December 31, 2022 | 0.2202 |
| September 30, 2022 | 0.1489 |
| June 30, 2022 | 0.1694 |
| March 31, 2022 | 0.3443 |
| December 31, 2021 | 0.2641 |
| September 30, 2021 | 0.2375 |
| June 30, 2021 | 0.1965 |
| March 31, 2021 | 0.1358 |
| December 31, 2020 | 0.1522 |
| September 30, 2020 | 0.6887 |
| Date | Value |
|---|---|
| June 30, 2020 | 0.5739 |
| March 31, 2020 | 0.575 |
| December 31, 2019 | 0.1123 |
| September 30, 2019 | 0.5454 |
| June 30, 2019 | 0.3787 |
| March 31, 2019 | 0.3868 |
| December 31, 2018 | 0.2389 |
| September 30, 2018 | 0.2365 |
| June 30, 2018 | 0.2317 |
| March 31, 2018 | 0.3134 |
| December 31, 2017 | 0.1672 |
| September 30, 2017 | 0.2315 |
| June 30, 2017 | 0.1929 |
| March 31, 2017 | 0.1985 |
| December 31, 2016 | 0.1169 |
| September 30, 2016 | 0.1374 |
| June 30, 2016 | 0.1926 |
| March 31, 2016 | 0.1535 |
| December 31, 2015 | 0.1354 |
| September 30, 2015 | 0.1754 |
| June 30, 2015 | 0.1555 |
| March 31, 2015 | 0.1496 |
| December 31, 2014 | 0.1175 |
| September 30, 2014 | 0.1255 |
| June 30, 2014 | 0.1215 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Takeda Pharmaceutical Co., Ltd. | 0.3736 |
| Daiichi Sankyo Co., Ltd. | 0.2857 |
| Eisai Co., Ltd. | 0.065 |
| Santen Pharmaceutical Co., Ltd. | 0.1611 |
| Ono Pharmaceutical Co., Ltd. | 0.0923 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 901.42M |
| Revenue (Quarterly) | 2.542B |
| Total Expenses (Quarterly) | 1.640B |
| Enterprise Value | 68.64B |
| Gross Profit Margin (Quarterly) | 70.58% |
| Profit Margin (Quarterly) | 35.47% |
| Earnings Yield | 4.32% |
| Operating Earnings Yield | 6.04% |
| Normalized Earnings Yield | 4.396 |